medRxiv
Blood aging clock may reflect disease burden in cancer
In an observational study of 3,067 patients having primary tumors removed, one or two blood components accounted for PhenoAge’s link to cancer outcomes.In an observational study of 3,067 patients having primary tumors removed, one or two blood components accounted for PhenoAge’s link to cancer outcomes.
Preprint: cohort study of 3,067 peopleCancer
Who was studied3,067 patients undergoing primary tumor resection
What changedBlood-based age estimates rose relative to patients’ actual ages as tumor stage increased
The catchBiological aging was represented by a blood clock, rather than an independent aging measure